Hologic has launched its new Genius Digital Diagnostics System for cervical cancer screening in Europe.

A digital cytology platform, the new system helps cytotechnologists and pathologists to detect pre-cancerous lesions and cancer cells in women by combining a new artificial intelligence (AI) algorithm with volumetric imaging technology.

It comprises the Genius Image Management Server to store images, Genius Digital Imager for acquiring images, Genius Cervical AI algorithm to analyse images and Genius Review Station for performing case reviews.

The new platform is designed to improve workflow and lab efficiency as well as provide actionable insights to eradicate cervical cancer.

Hologic international strategic development diagnostics vice-president Andrew Pieprzyk said: “We strive to develop innovative solutions that meet our customers’ needs. We are delighted in the overwhelming positive feedback from the customers who have been the first in the world to use this technology.

“The technology enhances the capabilities of individual laboratories and also has the potential to radically transform how cervical cancer screening is carried out, by enabling laboratories within the same network to collaborate across the world to manage the caseload.”

The CE-marked Genius Digital Diagnostics System has the capability to analyse all cells on a ThinPrep Pap test image and curate a single view of objects that are clinically relevant.

This system provides healthcare providers with crucial information that can help guide earlier detection, as well as improved treatment decisions for patients.

It also enables dynamic collaboration across laboratories in a network and connects pathologists with remote review capabilities.

The scalable system has also been designed to ensure that it fits current and future laboratory requirements.